Hypertension Trial, Recruiting NCT06891911 Sponsor: Beth Israel Deaconess Medical Center Condition: Hypertension
Back to Hypertension

Hypertension Trial, Recruiting

NCT06891911
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People whose resting blood pressure readings fall within a specific range: systolic (top number) between 120 and below 160, and diastolic (bottom number) below 110
  • People who currently live in Florida, Georgia, or Tennessee
  • People who are able to receive home-delivered groceries or collect them from a nearby location, and who are willing to eat only the provided groceries for 4 weeks
  • People who have access to a fridge, cooking appliances, and internet or mobile data service at home
  • People who have access to a mobile phone or computer and are able to join video calls and send and receive text messages
  • People who are willing and able to complete the required measurements throughout the study
  • People who are able to give their own consent to participate in the study
  • People who have access to a primary care doctor, urgent care centre, or emergency room that the study team can refer them to if needed during the study

Who may not be able to join:

  • People whose blood test shows potassium levels that are too high (at or above 5.0 mmol/L) or too low (below 3.5 mmol/L)
  • People whose kidney function test result (eGFR) is below 30, indicating significantly reduced kidney function
  • People whose blood sugar (HbA1c) test result is at or above 6.5%, which is the threshold used to diagnose diabetes
  • People whose doses of certain medications have changed in the 6 months before the study, or are planned to change during the study — this includes weight-management injections (such as GLP-1 or dual GLP-1/GIP medicines), blood pressure medications, SGLT2 inhibitors (a type of diabetes medicine), or other blood sugar-lowering medications
  • People who regularly take potassium supplements (unless it is only the small amount found in a standard multivitamin)
  • People who take warfarin (also known as Coumadin), a blood-thinning medication
  • People who take oral steroid medications on an ongoing basis (occasional use may be acceptable — confirm with trial site)
  • People who take non-GLP-1 weight loss medications
  • People who take sulfonylurea medications or any form of insulin for blood sugar management
  • People taking any other medication that the investigators determine is not compatible with participation
  • People whose blood pressure reading at screening is below 120 or at or above 160 (systolic), or at or above 110 (diastolic)
  • People whose upper arm measurement is greater than 52 cm, or exceeds the upper limit of the blood pressure device used in the study
  • People who report losing or gaining 15 or more pounds in the 2 months before joining
  • People who have had a recent serious heart or blood vessel event in the past 6 months, such as a heart attack, stroke, heart bypass surgery, coronary procedure, or a hospital admission for heart failure
  • People who have been diagnosed with or treated for cancer in the last 2 years (some early-stage or skin cancers not requiring systemic treatment may be acceptable — confirm with trial site)
  • People who have had stomach or bowel surgery, or have a digestive condition that affects how the body absorbs food, or that requires a special diet that would conflict with the study's required eating plan
  • People who are currently pregnant, breastfeeding, or planning to become pregnant during the study period
  • People who have visited an emergency department in the last 6 months due to asthma or chronic obstructive pulmonary disease (COPD)
  • People who have been hospitalised due to dangerously low blood sugar in the last 12 months
  • People with any other serious health condition that the investigators determine is not compatible with participation
  • People with significant food allergies, strong food dislikes, intolerances, or dietary needs that would make it difficult to follow the study's required diet
  • People who drink more than 14 alcoholic drinks per week, or more than 6 drinks on a single occasion on one or more days per week
  • People with an active substance use disorder that would interfere with taking part in the study
  • People experiencing extreme food insecurity
  • People who are currently in a weight loss program or planning to join one during the study
  • People who are currently participating in another clinical trial that could interfere with this study
  • People who expect to move out of Florida, Georgia, or Tennessee before the study ends
  • Households where more than 6 adults regularly eat dinner together (with children counted as half an adult each)
  • People whom the investigators determine are not suitable for participation for any other reason

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 2 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
14 October 2025
Est. completion
1 June 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Self-measured systolic blood pressure

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 2 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov